Current Neuro-Oncology
Volume
25 Number 17
15 September 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 17, 15 September
Ansari SA, Roohi M, Al Doseri KA,
Alsindi KA, Almayman TA.
Glioblastoma
with Primitive
Neuroectodermal Tumor like Component: Rare and Enigmatic.
Gulf
J Oncolog. 2023
Sep;1(43):74-77∟.
PMID: 37732531∟.
Case report. ˍ
*
Umemura Y, Orringer D, Junck L,
Varela ML, West MEJ, Faisal SM, Comba A, Heth J, Sagher O, Leung
D, Mammoser A, Hervey-Jumper S, Zamler D, Yadav VN, Dunn P,
Al-Holou W, Hollon T, Kim MM, Wahl DR, Camelo-Piragua S, Lieberman
AP, Venneti S, McKeever P, Lawrence T, Kurokawa R, Sagher K,
Altshuler D, Zhao L, Muraszko K, Castro MG, Lowenstein
PR.
Combined
cytotoxic and immune-stimulatory gene therapy for primary adult
high-grade glioma: a phase 1, first-in-human trial.
Lancet
Oncol. 2023 Sep;24(9):1042-1052∟.
doi: 10.1016/S1470-2045(23)00347-9∟.
PMID: 37657463∟.
Interventional
study˰ ˍ
Sun L, Kienzler JC, Reynoso JG, Lee
A, Shiuan E, Li S, Kim J, Ding L, Monteleone AJ, Owens GC,
Phillips JJ, Everson RG, Nathanson D, Cloughesy TF, Li G, Liau LM,
Hugo W, Kim W, Prins RM.
Immune
checkpoint blockade induces distinct alterations in the
microenvironments of primary and metastatic brain tumors.
J
Clin Invest. 2023 Sep 1;133(17):e169314∟.
doi: 10.1172/JCI169314∟.
PMID: 37655659∟.
Laboratory investigation. ˍ
Yuan J, Liu J, Fan R, Liu Z.
Effect
of Temozolomide Combined with Intensity Modulated Radiation
Therapy on Serum Factor, Immune Function and Clinical Efficacy in
Postoperative Glioma Patients.
Radiat
Res. 2023 Sep 1;200(3):289-295∟.
doi: 10.1667/RADE-22-00198. PMID: 37797165∟.
Observational study˰ ˍ
*
Corti C, Oldrati V, Papini M,
Strazzer S, Poggi G, Romaniello R, Borgatti R, Urgesi C, Bardoni
A.
Randomized
clinical trial on the effects of a computerized cognitive training
for pediatric patients with acquired brain injury or congenital
malformation.
Sci
Rep. 2023 Sep 4;13(1):14559∟.
doi: 10.1038/s41598-023-41810-1∟.
PMID: 37666983∟.
Interventional
study. ˍ
Karschnia P, Dietrich J, Bruno F,
Dono A, Juenger ST, Teske N, Young JS, Sciortino T, Häni L,
van den Bent M, Weller M, Vogelbaum MA, Morshed RA, Haddad AF,
Molinaro AM, Tandon N, Beck J, Schnell O, Bello L, Hervey-Jumper
S, Thon N, Grau SJ, Esquenazi Y, Rudà R, Chang SM, Berger
MS, Cahill DP, Tonn JC.
Surgical
management and outcome of newly diagnosed glioblastoma without
contrast enhancement ('low grade appearance') - a report of the
RANO resect group.
Neuro
Oncol. 2023 Sep 4:noad160∟.
doi: 10.1093/neuonc/noad160∟.
PMID: 37665776∟.
Observational study. ˍ
*
Roll W, Müther M, Böning
G, Delker A, Warneke N, Gildehaus FJ, Schäfers M, Stummer W,
Zeidler R, Reulen HJ, Stegger L.
First
clinical experience with fractionated intracavitary
radioimmunotherapy using [177Lu]Lu-6A10-Fab
fragments in patients with glioblastoma: a pilot study.
EJNMMI
Res. 2023 Sep 4;13(1):78∟.
doi: 10.1186/s13550-023-01029-7∟.
PMID: 37665396∟.
Interventional
study. ˍ
Sinha S, Avnon A, Perera A,
Lavrador JP, Ashkan K.
Butterfly
gliomas: a time for stratified management?
Neurosurg
Rev. 2023 Sep 4;46(1):223∟.
doi: 10.1007/s10143-023-02126-w∟.
PMID: 37665387∟.
Observational study. ˍ
Chen W, Guo S, Wang Y, Shi Y, Guo
X, Liu D, Li Y, Wang Y, Xing H, Xia Y, Li J, Wu J, Liang T, Wang
H, Liu Q, Jin S, Qu T, Li H, Yang T, Zhang K, Wang Y, Ma W.
Novel
insight into histological and molecular astrocytoma, IDH-mutant,
Grade 4 by the updated WHO classification of central nervous
system tumors.
Cancer
Med. 2023 Sep 5∟.
doi: 10.1002/cam4.6476∟.
PMID: 37667984∟.
Observational study. ˍ
Cifarelli CP, Vargo JA, Sener U,
Cifarelli DT, Scoville D, Dabir A.
Intracranial
intraoperative radiotherapy (IORT): evaluation of
electrocorticography and peri-operative seizure risk.
J
Neurooncol. 2023 Sep 5∟.
doi: 10.1007/s11060-023-04443-y∟.
PMID: 37668944∟.
Observational study˰ ˍ
Murtha AN, Zaki PG, Shepard
MJ.
Letter
to the editor: outcome of glioblastoma patients after intensive
care unit admission with invasive mechanical ventilation: a
multicenter analysis.
J
Neurooncol. 2023 Sep 5∟.
doi: 10.1007/s11060-023-04434-z∟.
PMID: 37668942∟.
Letter˰ ˍ
Wood MD, Beadling C, Neff T, Moore
S, Harrington CA, Baird L, Corless C.
Molecular
profiling of pre- and post-treatment pediatric high-grade
astrocytomas reveals acquired increased tumor mutation burden in a
subset of recurrences.
Acta
Neuropathol Commun. 2023 Sep 5;11(1):143∟.
doi: 10.1186/s40478-023-01644-4∟.
PMID: 37670377∟.
Laboratory investigation. ˍ
Wu YY, Chen KT, Chu YC, Yeh CC,
Chen WC, Chen PY, Chang WH, Wei KC, Chen YC.
Neuropsychological
impairment in primary malignant brain tumor patients with awake
craniotomy: a hospital-based registration study.
J
Neurooncol. 2023 Sep 5∟.
doi: 10.1007/s11060-023-04431-2∟.
PMID: 37668943∟.
Observational study˰ ˍ
Lohmeier J, Radbruch H, Brenner W,
Hamm B, Hansen B, Tietze A, Makowski MR.
Detection
of recurrent high-grade glioma using microstructure
characteristics of distinct metabolic compartments in a multimodal
and integrative 18F-FET PET/fast-DKI approach.
Eur
Radiol. 2023 Sep 6∟.
doi: 10.1007/s00330-023-10141-0∟.
PMID: 37672058∟.
Observational study. ˍ
Gilis N, Lebrun L, Lolli V, David P, Rodesch M, Bex A, Fricx C, De
Maertelaer V, Salmon I, De Witte O.
Radiological
characterization of pediatric intramedullary astrocytomas: Do they
differ from adults?
Brain
Spine. 2023 Sep 7;4:102671. doi:
10.1016/j.bas.2023.102671. PMID:
38510632. Observational study. ˍ
He L, Zhang H, Li T, Yang J, Zhou
Y, Wang J, Saidaer T, Liu X, Wang L, Wang Y.
Distinguishing
Tumor Cell Infiltration and Vasogenic Edema in the Peritumoral
Region of Glioblastoma at the Voxel Level via Conventional MRI
Sequences.
Acad
Radiol. 2023 Sep 7:S1076-6332(23)00407-5∟.
doi: 10.1016/j.acra.2023.08.008? PMID: 37689557∟.
Observational study˰ ˍ
*
Ahluwalia MS, Rogers LR, Chaudhary
R, Newton H, Ozair A, Khosla AA, Nixon AB, Adams BJ, Seon BK,
Peereboom DM, Theuer CP.
Endoglin
inhibitor TRC105 with or without bevacizumab for
bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase
II trial.
Commun
Med (Lond). 2023 Sep 8;3(1):120∟.
doi: 10.1038/s43856-023-00347-0∟.
PMID: 37684373∟.
Interventional
study. ˍ
*
Nduom EK, Glod J, Brown DA, Fagan
M, Dalmage M, Heiss J, Steinberg SM, Peer C, Figg WD, Jackson
S.
Clinical
protocol: Feasibility of evaluating abemaciclib
neuropharmacokinetics of diffuse midline glioma using intratumoral
microdialysis.
PLoS
One. 2023 Sep 8;18(9):e0291068∟.
doi: 10.1371/journal.pone.0291068∟.
PMID: 37682953∟.
Interventional
study protocol. ˍ
Cheng 程梦雨
M,
Pang S, Wang Z, Zhao Y, Li W.
Clinical
value of a nomogram model based on apparent diffusion coefficient
values within 1 cm of the tumor cavity to predict postoperative
progression of glioma.
World
Neurosurg. 2023 Sep 9:S1878-8750(23)01266-4∟. doi:
10.1016/j.wneu.2023.09.015∟. PMID: 37696435∟.
Observational study˰ ˍ
Rim MH, Barada F, Levitsky
AM.
Recent
and anticipated novel drug approvals for 2023 and 2024.
Am
J Health Syst Pharm. 2023 Sep 9:zxad220∟.
doi: 10.1093/ajhp/zxad220∟.
PMID: 37688502∟.
Observational study˰ ˍ
Cui M, Liu Y, Zhou C, Chen H, Gao
X, Liu J, Guo Q, Guan B, Ma X.
Resection
of high-grade glioma involving language areas assisted by
multimodal techniques under general anesthesia: a retrospective
study.
Chin
Neurosurg J. 2023 Sep 11;9(1):25∟.
doi: 10.1186/s41016-023-00340-5∟.
PMID: 37691110∟.
Observational study. ˍ
Seitzman BA, Anandarajah H,
Dworetsky A, McMichael A, Coalson RS, Agamah AM, Jiang C, Gu H,
Barbour DL, Schlaggar BL, Limbrick DD, Rubin JB, Shimony JS,
Perkins SM.
Cognitive
deficits and altered functional brain network organization in
pediatric brain tumor patients.
Brain
Imaging Behav. 2023 Sep 11∟.
doi: 10.1007/s11682-023-00798-y∟.
PMID: 37695507∟.
Observational study˰ ˍ
Aktekin EH, Kütük MÖ,
Sangün Ö, Yazıcı N, Çaylaklı F,
Erol İ, Sarıalioğlu F.
Late
effects of medulloblastoma treatment: multidisciplinary approach
of survivors.
Childs
Nerv Syst. 2023 Sep 12∟.
doi: 10.1007/s00381-023-06146-1∟.
PMID: 37698649∟.
Observational study˰ ˍ
Dimov D, Brainman D, Berger B,
Coras R, Grote A, Simon M.
The
role of cytoreductive surgery in multifocal/multicentric
glioblastomas.
J
Neurooncol. 2023 Sep 12∟.
doi: 10.1007/s11060-023-04410-7∟.
PMID: 37697210∟.
Observational study. ˍ
Faye MD, Easaw J, De Robles P,
Agnihotram R, Torres-Vasquez A, Lamonde F, Petrecca K, Owen S,
Panet-Raymond V, Shenouda G, Souhami L, Azam M, Hossain B, Alkass
J, Sabri S, Abdulkarim B.
Phase
II trial of concurrent sunitinib, temozolomide, and radiotherapy
with adjuvant temozolomide for newly diagnosed MGMT unmethylated
glioblastoma.
Neurooncol
Adv. 2023 Sep 12;5(1):vdad106∟.
doi: 10.1093/noajnl/vdad106∟.
PMID: 37771465∟.
Interventional study. ˍ
Prins R, Everson R, Hugo W, Sun L,
Antonios J, Lee A, Ding L, Bu M, Khattab S, Chavez C,
Billingslea-Yoon E, Salazar A, Ellingson B, Cloughesy T, Liau
L.
Dendritic
Cell Vaccination in Conjunction with a TLR Agonist Polarizes
Interferon Immune Responses in Malignant Glioma Patients.
Res
Sq [Preprint]. 2023 Sep 12:rs.3.rs-3287211∟.
doi: 10.21203/rs.3.rs-3287211/v1∟.
PMID: 37790490∟.
Interventional study. ˍ
Sferruzza G, Finocchiaro
G.
Glioblastoma
immunotherapy: time for hope?
Neurol
Sci. 2023 Sep 12∟.
doi: 10.1007/s10072-023-07066-3∟.
PMID: 37700174∟.
Letter˰ ˍ
Al Sharie S, Abu Laban D, Nazzal J,
Iqneibi S, Ghnaimat S, Al-Ani A, Al-Hussaini M.
Midline
Gliomas: A Retrospective Study from a Cancer Center in the
Middle
East.
Cancers
(Basel). 2023 Sep 13;15(18):4545∟.
doi: 10.3390/cancers15184545∟.
PMID: 37760513∟.
Observational study. ˍ
Bruschi M, Midjek L, Ajlil Y, Vairy
S, Lancien M, Ghermaoui S, Kergrohen T, Verreault M, Idbaih A, de
Biagi CAO Jr, Liu I, Filbin MG, Beccaria K, Blauwblomme T, Puget
S, Tauziede-Espariat A, Varlet P, Dangouloff-Ros V, Boddaert N, Le
Teuff G, Grill J, Montagnac G, Elkhatib N, Debily MA, Castel
D.
Diffuse
Midline Glioma Invasion and Metastasis Rely on Cell-autonomous
Signaling.
Neuro
Oncol. 2023 Sep 13:noad161∟.
doi: 10.1093/neuonc/noad161∟.
PMID: 37702430∟.
Laboratory investigation. ˍ
Jabehdar Maralani P, Stewart J,
Hiremath S, Lawrence L, Chan R, Lau A, Chen H, Chan A, Zeng LK,
Tseng CL, Myrehaug S, Soliman H, Detsky J, Heyn C, Lim Fat M,
Lipsman N, Sahgal A.
Relationship
between apparent diffusion coefficient and survival as a function
of distance from gross tumor volume on radiation planning MRI in
newly diagnosed glioblastoma.
J
Neurooncol. 2023 Sep 14∟.
doi: 10.1007/s11060-023-04440-1∟.
PMID: 37707752∟.
Observational study˰ ˍ
Hoogendijk R, van der Lugt J, Baugh
J, Kline C, Kranendonk M, Hoving E, Kremer L, Wesseling P,
Karim-Kos H, van Vuurden D.
Sex-related
incidence and survival differences in pediatric high-grade glioma
subtypes: A population-based cohort study.
iScience.
2023 Sep 15;26(10):107957∟.
doi: 10.1016/j.isci.2023.107957∟.
PMID: 37810231∟.
Observational study. ˍ